Characteristic | |
---|---|
Age – years | 67.1 ± 18.0 |
Male sex – no. (%) | 314 (62.6) |
Smoking status | |
- Current smoker – no. (%) | 135 (24.8) |
- Packyears history in smokers | 40.0 ± 24.9 |
Antibiotic pretreatment (%) | 110 (20.2) |
Underlying disease – no. (%) | |
- Coronary artery disease | 156 (28.6) |
- Hypertensive heart disease | 95 (17.4) |
- Congestive heart failure | 34 (6.2) |
- Peripheral vascular disease | 39 (7.2) |
- Cerebrovascular disease | 25 (4.6) |
- Renal dysfunction | 121 (22.2) |
- Liver disease | 43 (7.9) |
- Diabetes mellitus | 93 (17.1) |
- Neoplastic disease | 65 (11.9) |
Symptoms – no. (%) | |
- Cough | 497 (91.2) |
- Sputum | 390 (71.6) |
- Dyspnea | 392 (71.9) |
Signs– no. (%) | |
- Rales | 394 (72.3) |
Final diagnoses – no. (%) | |
- CAP | 373 (68.4) |
- Other respiratory tract infections | 132 (24.2) |
- Asthma | 13 (2.4) |
- Acute bronchitis | 59 (10.8) |
- Acute exacerbation of COPD | 60 (11.0) |
- Others | 40 (7.3) |
- With infiltrate on chest radiography | 23 (4.2) |
- Without infiltrate on chest radiography | 17 (3.1) |
PSI in patients with CAP – points | 96.4 ± 36.0 |
PSI class – no. (%) | |
- I, II and III | 162 (43.4) |
- IV | 150 (40.2) |
- V | 61 (16.4) |
Laboratory parameters | |
hsCRP (mg/L) (mean; median (range)) | 127.9; 103.4 (0.5–512) |
PCT (μg/L) (mean; median (range)) | 3.1; 0.32 (0.02–234.7) |
Leukocyte count (×109/L) | 12.9 ± 6.7 |